Elenbecestat Uses, Dosage, Side Effects and more
Elenbecestat is under investigation in clinical trial NCT02956486 (A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Subjects With Early Alzheimer's Disease).
| Trade Name | Elenbecestat |
| Generic | Elenbecestat |
| Elenbecestat Other Names | Elenbecestat |
| Type | |
| Formula | C19H18F3N5O2S |
| Weight | Average: 437.44 Monoisotopic: 437.113330503 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
